Esperion Therapeutics, Inc.

ESPR · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.8B · 294 employees
261
SEC Filings
$3.18
Close 2026-07-10
294
Employees

Business Summary

Esperion Therapeutics is a commercial-stage biopharmaceutical company focused on cardiovascular disease. It develops and commercializes oral, once-daily, non-statin medicines NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) to reduce LDL-C and cardiovascular risk in adults unable or unwilling to take statins. Products are approved by the FDA, European Commission, and Swissmedic, with international partnerships covering Japan, Canada, Israel, and Australia.

Latest Stock Quote

ESPR 2026-07-10 $3.18 O:$3.18 H:$3.19 L:$3.18 Vol:59.1M VWAP:$3.1823
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-08

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001628280-26-016522EDGAR109K words
2025-03-072024-12-310001628280-25-011154EDGAR102K words
2024-02-272023-12-310001628280-24-007066EDGAR92K words
2023-02-212022-12-310001628280-23-004167EDGAR90K words
2022-02-222021-12-310001628280-22-003263EDGAR—
2021-02-232020-12-310001628280-21-002865EDGAR—
2020-02-272019-12-310001104659-20-026203EDGAR—
2019-02-282018-12-310001047469-19-000791EDGAR—
2018-02-202017-12-310001047469-18-000899EDGAR—
2017-02-222016-12-310001047469-17-000831EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001628280-25-050165EDGAR34K words
2025-08-132025-06-300001628280-25-040139EDGAR31K words
2025-05-082025-03-310001628280-25-023498EDGAR26K words
2024-11-072024-09-300001628280-24-046307EDGAR32K words
2024-08-122024-06-300001628280-24-036762EDGAR31K words
2024-05-072024-03-310001628280-24-020862EDGAR29K words
2023-11-072023-09-300001628280-23-037195EDGAR31K words
2023-08-012023-06-300001628280-23-026358EDGAR30K words
2023-05-092023-03-310001628280-23-016646EDGAR28K words
2022-11-012022-09-300001628280-22-027479EDGAR—
2022-08-022022-06-300001628280-22-020111EDGAR—
2022-05-032022-03-310001628280-22-011885EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-07-130001104659-26-082926EDGAR18K words
2026-04-020001628280-26-023196EDGAR77K words
2026-03-100001628280-26-016230EDGAR4K words
2026-03-030001628280-26-013552EDGAR2K words
2026-01-120001628280-26-001764EDGAR3K words
2025-11-060001628280-25-049866EDGAR4K words
2025-11-040001628280-25-048557EDGAR1K words
2025-10-080001104659-25-097992EDGAR1K words
2025-10-070001104659-25-097506EDGAR5K words
2025-08-050001628280-25-037601EDGAR3K words

261 total filings indexed. 229 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

cardiovascular-disease-prevention ldl-c-lowering-therapy primary-hyperlipidemia-treatment statin-intolerant-patient-population primary-and-secondary-cardiovascular-prevention

Company Identity

CIK0001434868
TickerESPR
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.esperion.com
Listed2013-06-26

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 7de107207cc63c69e1cecf01431ad76ab780c0c82b0bfa5e183b2c90fc636662
parent: c0531d3d99cb04e1ab825a3bca0e69fcce0afb784a73dd493b94b3059b911436
content hash: a5336aacc969170e38e95ffcaa70572190347c2c2d55b594dce9e5eddd5863ed
signed: 2026-09-29T12:01:16.421Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ESPR using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ESPR, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ESPR (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.